Login
The Society
Board of Directors
CHS Bylaws
Newsletter-As of Jan. 2021 eNews is sent to members
Choosing Wisely Canada
Upcoming Events
Awards
Annual Research Abstract Awards
Canadian Hematology Paper of the Year Award
RK Smiley Research Grant Program
CHS Lifetime Achievement Award
Early Career Award
Hematology Trainee Educational and Quality Improvement Award
Membership
Careers
Careers
Fellowships
Members – Portal
Continuing Education – Webinars
Continuing Education – Case Studies
Pan-Canadian Case Study Challenge
Contact Us
Sponsorship Opportunities
The Society
Board of Directors
CHS Bylaws
Newsletter-As of Jan. 2021 eNews is sent to members
Choosing Wisely Canada
Upcoming Events
Awards
Annual Research Abstract Awards
Canadian Hematology Paper of the Year Award
RK Smiley Research Grant Program
CHS Lifetime Achievement Award
Early Career Award
Hematology Trainee Educational and Quality Improvement Award
Membership
Careers
Careers
Fellowships
Members – Portal
Continuing Education – Webinars
Continuing Education – Case Studies
Pan-Canadian Case Study Challenge
Contact Us
Sponsorship Opportunities
The Next Frontier in Immunotherapy for Multiple Myeloma: What Will BCMA Targeting Mean for Our Relapsed/Refractory Patients? Video Activity
Home
>
« All Events
The Next Frontier in Immunotherapy for Multiple Myeloma: What Will BCMA Targeting Mean for Our Relapsed/Refractory Patients? Video Activity
July 12, 2025 @ 08:00
-
January 10, 2027 @ 17:00
EDT
«
ISLH 2025 the 38th International Symposium on Technological Innovations in Laboratory Hematology – Halifax, Nova Scotia
Add to calendar
Google Calendar
iCalendar
Outlook 365
Outlook Live
Details
Start:
July 12 @ 08:00
EDT
End:
January 10, 2027 @ 17:00
EDT
Website:
http://www.peervoice.com/PUP800
Venue
Virtual
Canada
